Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis in Behçet's disease.

J D O'Duffy1

  • 1Mayo Medical School, Mayo Clinic, Rochester, Minnesota.

Rheumatic Diseases Clinics of North America
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Behçet's disease commonly involves vasculitis affecting arteries and veins, posing life-threatening risks when impacting major vessels. Immunosuppressive treatments have significantly improved outcomes for both vision and survival in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical images: The iron salute: a sign of hemochromatosis.

Arthritis and rheumatism·2011
Same author

Is there a place for large vessel disease in the diagnostic criteria of Behçet's disease?

The Journal of rheumatology·1999
Same author

Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy.

Neurology·1999
Same author

A study of the cutaneous manifestations of Behçet's disease in patients from the United States.

Journal of the American Academy of Dermatology·1999
Same author

Whipple's arthritis: direct detection of Tropheryma whippelii in synovial fluid and tissue.

Arthritis and rheumatism·1999
Same author

Improvement of myelopathy in Sjögren's syndrome with chlorambucil and prednisone therapy.

Neurology·1999
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Neurology

Background:

  • Vasculitis is a key characteristic of Behçet's disease, affecting both arteries and veins.
  • Vascular involvement, particularly in systemic or pulmonary arteries and large veins, presents a significant life-threatening risk.
  • Retinal vasculitis is a defining feature of ocular manifestations, while central nervous system disease is often associated with small artery occlusions.

Purpose of the Study:

  • To highlight the critical role of vasculitis in Behçet's disease.
  • To underscore the severity of vascular complications in Behçet's disease.
  • To discuss the impact of immunosuppressive therapy on patient prognosis.

Main Methods:

  • Review of clinical features and disease manifestations of Behçet's disease.

Related Experiment Videos

  • Analysis of the impact of vasculitis on different organ systems (eyes, CNS, major vessels).
  • Evaluation of treatment outcomes with immunosuppressive drugs.

    • Main Results:

    • Vasculitis affects arteries and veins in Behçet's disease.
    • Systemic, pulmonary artery, and large vein involvement are life-threatening.
    • Retinal vasculitis and small artery occlusions in the CNS are significant clinical findings.

    Conclusions:

    • Vasculitis is a major determinant of morbidity and mortality in Behçet's disease.
    • Early recognition and treatment of vasculitis are crucial for improving patient outcomes.
    • Immunosuppressive therapy offers a promising approach to manage vascular complications and enhance prognosis for sight and life.